Seasonal variation of Raynaud's phenomenon secondary to systemic sclerosis

被引:1
|
作者
Watson, HR
Robb, R
Belcher, G
Belch, JJF
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Dept Med, Dundee DD1 9SY, Scotland
[2] Takeda Europe, R&D Ctr, Drug Safety, Frankfurt, Germany
关键词
Raynaud's phenomenon; systemic sclerosis; season; temperature;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective, Patients with systemic sclerosis (SSc) were assessed for 12 months to quantify the seasonal variation in Raynaud's phenomenon (RP) in patients with an underlying connective tissue disease. Methods. Eighteen patients with SSc (17 limited, 1 diffuse type) were studied. Raynaud's attacks were recorded in a daily diary for four 2-week periods at 3 month intervals, Daily number and duration of attacks and overall severity of RP were calculated for each 2-week period. Mean daily temperatures, measured and perceived, were obtained for each period. Results, In winter, patients had a mean of 2.9 attacks/day (SD +/- 1.1), daily duration 70 minutes (SD +/- 48) and a severity of score of 4.1 (SD +/- 2.0) out of 10. All 3 variables correlated with ambient outdoor temperature and varied significantly over the 12 months (p < 0.001) with mean reductions of 48, 50, and 56% respectively from winter to summer. Only 3 of 18 patients reported no attacks during the summer period. The mean measured and perceived outdoor temperatures increased from winter to summer by 10.6 and 14.3 degrees C, respectively. Conclusion. For patients with SSc, RP is a problem throughout the year. Symptoms may be reduced by about 50% in the summer months, but few patients experience complete relief.
引用
收藏
页码:1734 / 1737
页数:4
相关论文
共 50 条
  • [21] Raynaud's Phenomenon and Plasma Endothelin: Correlations with Capillaroscopic Patterns in Systemic Sclerosis
    Sulli, Alberto
    Soldano, Stefano
    Pizzorni, Carmen
    Montagna, Paola
    Secchi, Maria Elena
    Villaggio, Barbara
    Seriolo, Bruno
    Brizzolara, Renata
    Cutolo, Maurizio
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (06) : 1235 - 1239
  • [22] Plasma urotensin II levels in primary Raynaud's phenomenon and systemic sclerosis
    Gozel, Nevzat
    Karatas, Ahmet
    Yardim, Meltem
    Kinaci, Mesude Seda
    Ulu, Ramazan
    Demircan, Fatih
    Kilinc, Faruk
    Oz, Burak
    Donder, Emir
    Aydin, Suleyman
    Koca, Suleyman Serdar
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2017, 47 (06) : 1687 - 1692
  • [23] Systemic Sclerosis: Bilateral Improvement of Raynaud's Phenomenon with Unilateral Digital Sympathectomy
    Wasserman, Amy
    Brahn, Ernest
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2010, 40 (02) : 137 - 146
  • [24] Randomized Placebo-Controlled Crossover Trial of Tadalafil in Raynaud's Phenomenon Secondary to Systemic Sclerosis
    Schiopu, Elena
    Hsu, Vivien M.
    Impens, Ann J.
    Rothman, Jennifer A.
    McCloskey, Deborah A.
    Wilson, Julianne E.
    Phillips, Kristine
    Seibold, James R.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (10) : 2264 - 2268
  • [25] Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: A pilot study
    Sambo, P
    Amico, D
    Giacomelli, R
    Matucci-Cerinic, M
    Salsano, F
    Valentini, G
    Gabrielli, A
    JOURNAL OF RHEUMATOLOGY, 2001, 28 (10) : 2257 - 2262
  • [26] Homocysteine concentration in primary and systemic sclerosis associated Raynaud's phenomenon
    Marasini, B
    Casari, S
    Bestetti, A
    Maioli, C
    Cugno, M
    Zeni, S
    Turri, O
    Guagnelli, E
    Biondi, ML
    JOURNAL OF RHEUMATOLOGY, 2000, 27 (11) : 2621 - 2623
  • [27] Efficacy of cilostazol for the treatment of Raynaud’s phenomenon in systemic sclerosis patients
    Simone Negrini
    Francesca Spanò
    Elena Penza
    Daniela Rollando
    Francesco Indiveri
    Gilberto Filaci
    Francesco Puppo
    Clinical and Experimental Medicine, 2016, 16 : 407 - 412
  • [28] Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis
    Serri, J.
    Legre, R.
    Veit, V.
    Guardia, C.
    Gay, A. -M.
    ANNALES DE CHIRURGIE PLASTIQUE ESTHETIQUE, 2013, 58 (06): : 658 - 662
  • [29] Efficacy of cilostazol for the treatment of Raynaud's phenomenon in systemic sclerosis patients
    Negrini, Simone
    Spano, Francesca
    Penza, Elena
    Rollando, Daniela
    Indiveri, Francesco
    Filaci, Gilberto
    Puppo, Francesco
    CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 16 (03) : 407 - 412
  • [30] Management of Raynaud's phenomenon in systemic sclerosis-a practical approach
    Fernandez-Codina, Andreu
    Canas-Ruano, Esperanza
    Pope, Janet E.
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2019, 4 (02) : 102 - 110